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Abstract
Background: Despite the seriousness of dengue-related disease, with an estimated 50–100 million cases of dengue fever
and 250,000–500,000 cases of dengue hemorrhagic fever/dengue shock syndrome each year, a clear understanding of
dengue pathogenesis remains elusive. Because of the lack of a disease model in animals and the complex immune
interaction in dengue infection, the study of host response and immunopathogenesis is difficult. The development of
genomics technology, microarray and high throughput quantitative PCR have allowed researchers to study gene expression
changes on a much broader scale. We therefore used this approach to investigate the host response in dengue virus-
infected cell lines and in patients developing dengue fever.
Methodology/Principal Findings: Using microarray and high throughput quantitative PCR method to monitor the host
response to dengue viral replication in cell line infection models and in dengue patient blood samples, we identified
differentially expressed genes along three major pathways; NF-kB initiated immune responses, type I interferon (IFN) and
the ubiquitin proteasome pathway. Among the most highly upregulated genes were the chemokines IP-10 and I-TAC, both
ligands of the CXCR3 receptor. Increased expression of IP-10 and I-TAC in the peripheral blood of ten patients at the early
onset of fever was confirmed by ELISA. A highly upregulated gene in the IFN pathway, viperin, was overexpressed in A549
cells resulting in a significant reduction in viral replication. The upregulation of genes in the ubiquitin-proteasome pathway
prompted the testing of proteasome inhibitors MG-132 and ALLN, both of which reduced viral replication.
Conclusion/Significance: Unbiased gene expression analysis has identified new host genes associated with dengue
infection, which we have validated in functional studies. We showed that some parts of the host response can be used as
potential biomarkers for the disease while others can be used to control dengue viral replication, thus representing viable
targets for drug therapy.
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Introduction
Although dengue-related disease results in an estimated 50–100
million cases of dengue fever and 250,000 to 500,000 cases of
dengue hemorrhagic fever/dengue shock syndrome each year
[1,2], a clear understanding of dengue pathogenesis remains
elusive. Dengue virus is an enveloped, positive-stranded RNA
virus of the Flaviviridae family transmitted by the mosquito Aedes
aegypti and Aedes albopictus. Four serotypes of dengue virus (DENV1-
4) circulate in endemic areas. Although infection with one serotype
of dengue virus confers life-long protective immunity to that
serotype, it does not protect the host from infection with other
serotypes [3].
The initial target cells during dengue infection are believed to be
Langerhans cells [4]. Through means not yet fully understood,
Langerhans cells spread the virus, via the lymphatic system, to
other tissues such as liver, spleen, kidney and blood, whereas
monocytes, macrophages and endothelial cells are the major cell
types in which the virus replicates [5]. In the majority of
symptomatic dengue infections, a fever of 5–7 days duration
develops together with bone and joint pain, retro-orbital pain,
nausea and fatigue, this is called dengue fever (DF). While the
majority of DF patients recover without intervention, 2–5%
develop a more severe form of the disease, called dengue
hemorrhagic fever/dengue shock syndrome (DHF/DSS), charac-
terized by thrombocytopenia and vascular leakage, causing
hypervolemic shock and death if not promptly treated [6]. The
cause of DHF/DSS is not clear. Antibody dependent enhance-
ment (ADE) is the most widely supported theory explaining the
higher risk of DHF/DSS associated with a heterologous secondary
infection [7]. The phenomenon of T cell ‘‘original antigenic sin’’
has also been described [8]. Like many viruses, dengue inhibits
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IFNa and IFNb signaling by suppressing Jak-Stat activation,
resulting in reduced host antiviral response [9]. The combination
of a reduced host defense, increased uptake of the virus and
delayed viral clearance likely synergizes to produce higher viremia
resulting in a more severe outcome.
Because of the lack of a disease model in animals and the
complex immune interaction in dengue infection, the study of host
response and immunopathogenesis is difficult. The development of
genomics technology has allowed researchers to study gene
expression changes on a much larger scale. A summary of
published microarray data from infection of different host cell
types with bacteria, viruses, yeast, protozoa and helminthes
revealed a common host-transcriptional-response consisting of
a cluster of IFN-stimulated and immune mediating genes [10].
One particularly successful application of microarray technology
was the identification of a novel drug target, c-kit, in endothelial
cells infected with Kaposi’s sarcoma-associated herpesvirus
(KSHV) [11].
With regard to dengue infection, gene expression studies have
been carried out in infected human umbilical vein endothelial cells
(HUVECs) by differential display reverse transcription (DD-
RTPCR) and Affymetrix oligonucleotide microarrays [12]. Genes
having a role in the IFN antiviral response and immune defense
such as 29–59 oligoadenylate synthetase (OAS), myxovirus protein
A (MxA), TNFa, galectin-9, phospholipid scramblase 1 and
human inhibitor of apoptosis-1 (IAP1) were shown to be
upregulated upon infection [12]. Infection with dengue of a more
transformed HUVEC-like cell line, ECV304, was analyzed by
a different microarray system containing 7600 cDNA oligonucleo-
tides [13]. In this study, the expression of 15 genes involved in cell
cycle, apoptosis, membrane trafficking and cytoskeleton was found
to be altered after infection[13]. Using a different gene expression
approach, primary macrophages infected with a clinical isolate of
dengue were analyzed by a cytokine array containing 375 human
cytokine-related genes with approximately 20 genes observed to be
either up- or down- regulated [14]. However, the functional
importance of these changes, if any, was not studied [14].
We have used Compugen human 19K oligonucleotide arrays to
study the host response to dengue infection, initially in a human
hepatocytic cell line (HepG2). We identified the upregulation of
three major clusters of genes; NF-kB-mediated cytokine/chemokine
responses, type I IFN response, and the ubiquitin-proteasome
system. Increased expression of selected genes, identified by
Compugen array, was confirmed using a taqman low density array
(TLDA) and results extended to include an additional, readily
infectable, cell line (A549) and PBMC derived from adult dengue
fever patients from a Singapore dengue prospective cohort study.
Next we sought to confirm the functional effects of these
upregulated genes. We confirmed the high levels of two novel
chemokines, IP-10 and I-TAC, in dengue infection, in both cell lines
and in dengue patients. We also determined that overexpression of
viperin, an upregulated gene in the IFN pathway, and proteasome
inhibition, with MG-132 or ALLN, reduced virus replication. In
summary, we have used microarray analysis to identify new host
genes associated with dengue infection, and to show that
components of the host response can control dengue viral
replication and therefore represent potential targets for drug
therapy.
Materials and Methods
Cell lines and dengue virus
Cell lines, A549, BHK-21, C6/36, HeLa, HepG2, HUV-EC-C,
K562, SK-Hep1 and THP-1, were obtained from ATCC and
maintained as instructed. The type 2 dengue virus strain TSV01
was obtained from a dengue outbreak in Townsville, Australia
[15] (GenBank, accession number AY037116) and was propagated
in the C6/36 cell line. Heat-inactivated virus was prepared by
incubating virus samples in a 55uC water bath for 1 hr. Each cell
line was infected with dengue virus at a multiplicity of infection
(MOI) of 1 and 10 for 3, 6, 12, 24, 48, and 72 hrs before being
evaluated for replication efficiency by plaque assay. Infection of
cell lines was not continued beyond 72 hrs as after this point
a significant degree of cell death became apparent.
Plaque assay
BHK-21 cells were cultured overnight in 24 well plates before
media was removed and serial dilutions (10-fold) of virus culture
supernatants added to individual wells. Plates were incubated for
1 hr before media was aspirated and replaced with 0.5 ml of 0.8%
methyl-cellulose medium (with 2% FBS). Plates were then
incubated for 5 days before the media was removed and cells
fixed in 4% formaldehyde for 20 min, rinsed in water, stained with
crystal violet for 20 min then rinsed again. Plaques were counted
manually and concentrations of plaque forming units per ml (pfu/
ml) in the cell culture supernatant calculated. For drug in-
tervention studies, HepG2 cells were treated with compound, or
DMSO, at the indicated concentration and time. While the
culture supernatants were collected for plaque assay, cytotoxicity
in HepG2 cells was monitored using fluorescein diacetate (FDA,
Acros Organics, Belgium), 10 mg/ml added to cells for 25 min at
room temperature, and measured using a fluorescent plate reader
(485 nm excitation/535 nm emission).
Flow cytometry
Dengue E-protein was assessed in suspension HepG2 cells by
intracellular staining and fluorescence activated cell sorter (Becton
Dickinson, USA) and an Alexa-647 conjugated (AlexaFluor
conjugation kit, Invitrogen, USA) monoclonal antibody (4G2,
ATCC). Cells were scraped and permeabilized using BD FACS
Perm/Wash solution (Becton Dickinson, USA) and acquisition
and analysis was performed using CellQuest software (Becton
Dickinson, USA).
Author Summary
Dengue is the most prevalent mosquito-born viral disease
affecting humans, yet there is, at present, no drug
treatment for the disease nor are there any validated host
targets for therapeutic intervention. Using microarray
technology to monitor the response of virtually every
human gene, we aimed to identify the ways in which
humans interact with dengue virus during infection in
order to discover new therapeutic targets that could be
exploited to control viral replication. From the activated
genes, we identified three pathways common to in vitro
and in vivo infection; the NF-kB initiated immune pathway,
the type I interferon pathway, and the ubiquitin protea-
some pathway. We next found that inhibiting the ubiquitin
proteasome pathway, or activating the type I interferon
pathway, resulted in significant inhibition of viral replica-
tion. However, inhibiting the NF-kB initiated immune
pathway had no effect on viral replication. We suggest that
drugs that target the ubiquitin proteasome pathway may
prove effective at killing the dengue virus, and, if used
therapeutically, improve clinical outcome in dengue
disease.
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Virus quantification by real time RT-PCR
RNA was extracted from infected cells using the RNeasy Mini
Kit (Qiagen, Netherland). Dengue serogroup 2 virus TSV01
detection by TaqMan PCR was adapted to the ABI7900 real time
instrument using previously published primers and probes [16].
Standard ABI conditions were used, incorporating primers at
900nM. Quantification was achieved by relating viral Ct value to
the Ct value on a standard curve of a measured number of copies
of a 750 bp section of the virus (forward: 59-AAAGATCAGTGG-
CACTCGTTCC-39 and reverse: 59-GCAGGTCTAAGAAC-
CATTGCCT-39), cloned into pCR2.1-TOPO (Invitrogen, USA).
Microarray
Human arrays of 19,800 60mer oligonucleotide probes
(representing 18861 genes), designed by compugen and manu-
factured by Sigma-Genosys were used according to the standard
protocol described for cDNA microarray [17]. Dye swap was
performed for each sample, at every time point and a rigorous
quality check was performed before an array was used for
downstream analysis [18].
60 mer oligonucleotide probes were spotted onto poly-L-lysine-
coated microscope slides using GeneMachines OmniGrid Micro-
array Spotter (USA). For fluorescence labeling of target cDNAs,
20 mg of total RNA from universal human reference (Strategene,
USA) and experiment samples (RNA extracted from infected cells
using Qiagen RNeasy Mini Kit ) were reverse transcribed in the
presence of Cy3-dUTP and Cy5-dUTP (Amersham Biosciences,
UK) using the Superscript reverse transcription kit (Invitrogen,
USA). Labeled cDNA were pooled, concentrated, re-suspended in
DIG EasyHyb (Roche, Switzerland) buffer and hybridized over-
night (14-16h) in the MAUI Hybridization chamber (BioMicro,
USA). The arrays were scanned using a GenePix 4000B Scanner
(Axon Instruments, USA) to generate Tiff images. The images
were analyzed by GenePix Pro 4.0 software (Axon Instruments,
USA) to measure Cy3 and Cy5 fluorescence signals intensity and
format data for data base deposition. The array data then
underwent lowess normalization [19] available in an R package
aroma to remove channel specific biases (R Development Core
Team).
Selection of differentially expressed genes from
microarray data
Differentially expressed genes were selected using a procedure
known as Significance Analysis of Microarrays (SAM) [20],
described in brief below. The statistic used in SAM is given as
d~
m1{m2
szs0
where; the numerator is the group mean difference, s
the standard error, and s0 a regularizing constant. Setting s0 = 0
will yield a t-statistic. This value, called the fudge constant, is
found by removing the trend in d as a function of s in moving
windows across the data to reduce false positive results. As the
statistic is not t-distributed, significance is computed using
a permutation test. Genes with a computed statistic larger than
the threshold were considered significant. The false discovery rate
(FDR) associated with the given threshold can also be calculated
from the permutation data.
Quantitative PCR (qPCR) by TaqMan Low Density Array
(TLDA)
RNA was extracted using RNase Easy kit (Qiagen, Netherland)
from infected cells. For patients blood samples (see Patient
Samples), 2.5 ml of blood was collected in PAXgene tubes,
RNA was extracted using PAXgene Blood RNA Kit (PreAnalytiX,
Qiagne, Netherland). RNA was subjected to DNase treatment
using an RNase-Free DNase Set (Qiagen, Netherland). 100 ng of
total RNA was reverse transcribed using the High-Capacity cDNA
Archive Kit (ABI, USA) and processed for TaqMan Micro Fluidic
Cards (3M Company, ABI, USA) according to manufacturers
instructions, together with data analysis using SDS2.2 software
(ABI, USA). Differentially expressed genes were detected as above,
using SAM. We analyzed SAM gene lists using the Applied
Biosystem online program PANTHER [21] (http://www.
pantherdb.org/). Pathway, interaction and Gene Onotology
analysis was performed using MetaCore, version 3.2.0 (GeneGo,
Inc, USA).
Patient samples
Subjects were enrolled from the Early DENgue (EDEN) study,
a dengue investigation conducted at a primary healthcare clinic in
Singapore, for which local ethical approval had been granted, and
informed consent from patients obtained. Participation required
a PCR diagnosis of fever with duration less than 3 days (for the
details of the PCR diagnosis, see [22]). The enrolled dengue cases
were either of serotype 1 or 3. Ten dengue positive subjects
(n = 10, 3 males) were selected to represent the most severe cases of
dengue by the criteria of a platelet counts below 30 (x 103/ml;
range 8–30, mean 20.5). Their mean age was 43.2 years (range
24–67). The mean fever was 38.3uC (range 37.7–39.1) at the first
visit (Time Point 1), with a mean duration of 43 hours (range 14–
72) from the onset of the fever. The second visit (Time Point 2)
occurred at 80 to 96 hours after the first visit, mean fever was
37.1uC (range 36.2–38.7). Dengue negative patients were enrolled
with the same criteria (fever with no respiratory infection
symptoms), but were PCR negative for dengue. Ten subjects
were taken with (n = 10, 4 males) a mean age of 43.2 years old
(range 24–67). Their mean fever was 38.4uC (range 37.6–39.4)
with a mean duration 27 hrs (range 8–60) at the first visit (Time
Point 1). The convalescence sample was collected at the third visit
which was 3 to 4 weeks later (Time Point 3). At each time point,
a 2.5 ml blood sample was collected in PAXgene tubes for RNA
analysis. A 10 ml blood sample was collected, serum was separated
within 5 hrs and stored at 280uC. Serum IP-10 and I-TAC
concentrations were measured using ELISA kits from R&D
Systems as per manufacturers instructions.
Generation of A549 cells stably expressing viperin and
treatment with IFNb
A549 cells were transfected with an expression construct
encoding viperin using lipofectamine 2000 (Invitrogen, USA).
Cells were selected using 500 mg/ml G418 and screened for
viperin expression by immunoblotting. Cells were cultured over-
night in 6 well plates before IFNb (Glycoferon, Singapore), at
a final concentration of 500 U/ml, was added to each well while
control wells remained untreated. Twelve hours post IFNb
treatment, cells were infected with dengue virus (TSV01; MOI
1) for 48 hrs and the plaque assay was used to determine virus
production.
Results
Establishing an infection model for dengue virus
While a number of different cell lines have been used as models
for dengue infection it is not clear which of these represents the
most appropriate model for the analysis of host response by
microarray, which requires a high rate of infection. As such, we
screened seven human cell lines for their ability to support
replication of dengue virus. We used the clinical, dengue serotype
Gene Expression Profiling of Dengue Infection
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2 isolate TSV01 (Accession number: AY037116) strain for
infection. Human cell lines were ranked by maximum plaque
forming units (pfu)/ml titer produced with A549.HepG2.SK-
Hep1.K562.HUV-EC-C.THP-1.HeLa (data not shown).
The same results were obtained with the widely used NGC strain
(data not shown). The highest yielding cell lines A549 (a lung
carcinoma) and HepG2 (a hepatoma cell line) were used in further
studies, with HepG2 as the primary focus because of evidence of
liver injury in DHF/DSS and the detection of dengue antigens in
hepatocytes in liver [23,24].
Microarray identification of host responses to dengue
virus replication using the HepG2 infection model
Viral replication in HepG2 cells infected with dengue virus
TSV01 for 3, 6, 12, 24, 48 and 72 hours, compared to heat
inactivated virus, was determined by plaque assay of the virus
released in the cell culture medium (Figure 1A), FACS analysis of
infected cells labeled intracellularly with an Alexa 674-conjugated
antibody against dengue E protein (4G2) (Figure 1B) and real-time
PCR analysis of viral RNA (Figure 1C). All three methods showed
that new viral replication began after 24 hours and reached
a plateau at 72 hrs, with FACS analysis showing 28% of cells
infected at this point. After 72 hrs a degree of cell death become
apparent (data not shown) and the experiment was not continued.
Analysis of microarrays, performed in duplicate (dye-swapped) on
three biological replicates at each time point, comparing infectious
with heat inactivated virus; using a SAM q value (false discovery
threshold) of 25%, revealed no significantly differentially expressed
genes at 3, 6, 12 or 24 hrs post infection. However, there were 24
transcripts identified at 48 hrs and 124 at 72 hrs (a total of 132
transcripts representing 124 genes; Table S1) that were differen-
tially expressed. At both 48 hrs and 72 hrs, clustering of
transcripts using PANTHER analysis identified the IFN-mediated
immunity pathway as the most significant with a P value of 10215
(at 72 hrs). Genes that are typically induced after type I IFN
stimulation, including OAS1, OAS2, OAS3, OASL, STAT1,
STAT2, MX1, IFIH and IFNb, featured prominently in this
cluster (Figure 2 and Table S1). Further analysis of the 124 genes
suggested the involvement of NF-kB-mediated cytokine/chemo-
kine responses (NFKBIB, NFKB1A, TNFA1P, CCL4, CCL5, IP-
10 and I-TAC amongst others) and ubiquitin related genes
(HERC5, HERC6, UBE2L6, USP15 and others) (Figure 2).
Although not completely overlapping, a core host response to
pathogen involving the IFN response and the NF-kB-mediated
immune defense response [10] was observed in our array results.
Other genes that were significantly changed included those
associated with cell signaling, lipid metabolism, cell cycle and
vesicular transport (Table S1). We did not detect any significantly
down regulated genes in our system. All the microarray data were
deposited in a public database accessible at http://www.ncbi.nlm.
nih.gov/projects/geo (accession number is GSE6048).
Confirmation and validation of upregulated genes by
quantitative PCR in cell lines and in dengue patients
With the evidence of upregulation of three major pathways (NF-
kB, IFN and ubiquitin) by microarray, we decided to pursue these
pathways with further confirmation and validation. Firstly, we
chose 59 genes from the three major pathways that were
upregulated in the HepG2 cell line as shown by microarray.
Secondly we selected another 36 genes which had a functional
association with these pathways or might otherwise be associated
with dengue infection. A Taqman Low Density Array (LDA) was
then constructed for these 95 genes in order to confirm their
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Figure 1. Dengue replication in HepG2 cells. (A) HepG2 cells were
infected with dengue virus TSV01 (MOI 10) for 3, 6, 12, 24, 48 and
72 hrs. Cell culture supernatants were collected and assayed for dengue
virus by plaque assay. Plaque forming units per ml are expressed on
a log scale as mean6s.e.m. where n = 4. (B) HepG2 cells were infected
with dengue virus TSV01 (closed bars) or incubated with media alone
(open bars). Percentage of cells staining positive for dengue virus E-
protein by FACS are expressed as mean6s.e.m. where n= 3. (C) HepG2
cells were infected with dengue virus TSV01 (MOI 10) for 3, 6, 12, 24, 48
and 72 hrs. RNA was extracted and used to quantitate viral RNA copies
by Real Time PCR. The copy number is represented by dividing the cycle
detection threshold (Ct) value at the limit of detection (40) by the
sample Ct value (40/PCR units). One representative result is shown.
doi:10.1371/journal.pntd.0000086.g001
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expression by quantitative real time PCR. Results for the
HepG2 cell line indicated that there was again no significant
difference between infectious and heat-inactivated virus at
the 24 hr time point post-infection. At 48 hrs 31 of the 95
genes were differentially expressed, and at 72 hrs 62 of the 95
genes were differentially expressed (Table S2), indicating a high
rate of validation of the genes detected by microarray.
In order to exclude gene responses that were specific to the
HepG2 cell line alone, we decided to test the expression level of
these genes in the A549 cell line using the same LDA. In the A549
infection model, plaque assay revealed that peak viral production
occurred earlier than in the HepG2model (1.1610561.46104 pfu/
ml at 48 hrs) but was still substantial at 72 hrs post-infection
(7.3610463.86104 pfu/ml). The quantitative PCR also revealed
a higher number of differentially expressed genes, with 63 genes
at the 48 hr time point and 82 genes at the 72 hr time point
(Table S2).
Seeking confirmation that these genes were relevant in
a physiological setting, we sought to test these genes in dengue
patients. Whole blood RNA samples were obtained from ten adult
fever patients (age .21 years old) enrolled in the Singapore Early
Dengue (EDEN) cohort study in 2005 [22]. Each was PCR
diagnosed positive for either dengue serotype 1 or 3 and all
showed typical dengue fever symptoms. At the second visit
(,5 days after onset of fever, onset of fever considered day 1), their
platelet count had dropped below 30 (x 103/ml; range 8–30, mean
20.5), and they were admitted to hospital. When these patient
samples were tested for expression of the 95 selected genes by
LDA, 67 genes were shown to be differentially expressed
comparing blood samples taken at acute fever stage (first visit,
1–3 days after onset of fever) to convalescence (third visit, 3–
4 weeks after first visit) (Table S2).
After confirmation of the expression of certain genes in two
different dengue-infected cell lines and in dengue patients, we
Figure 2. Heat map of the microarray gene expression profile of HepG2 cells treated with live dengue virus TSV01 (V) or heat
inactivated TSV01 (H) transcripts identified as being differentially expressed by SAM analysis. Details on gene name, gene function,
SAM statistics, and fold change for all 132 selected transcripts are given in Table S1. Colour intensity is derived from mean relative expression fold
changes of dye swap results in comparison to universal reference (Strategene USA), red for upregulated, green for down regulated, black for no
change, and grey for missing data. Time course (3, 6, 12, 24, 48, 72 hours post infection) and triplicate (.1, .2, .3) are indicated on the x axis and genes
are grouped into three functional classes and clustered by expression profile on the y axis.
doi:10.1371/journal.pntd.0000086.g002
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selected those that were upregulated in at least one time point in
HepG2 cells and in at least one time point in A549 cells and in
dengue patient samples (comparing acute to convalescent blood
samples). Fifty genes fulfilled these criteria (Table S2) and, we felt,
represented common genes involved in dengue virus response, or
virus replication, while excluding responses that were cell type
specific. These 50 common genes were mapped by direct
interactions using the MetaCore program which illustrated the
close clustering and interconnectedness of a network of 29 of genes
around NF-kB, TNF-a and STAT1. (Figure 3A). The NF-kB gene
alone was added to the network, despite not being from our
common list, to illustrate the connections between those induced
by it. For example, the upregulation of IP-10, I-TAC, VEGF,
PAI1, B2M, TNFAIP3 and RIG-1 could all be linked to the
activation of NF-kB, while NFKB1B and NFKB1A, two feedback
control genes for NF-kB activation, were also upregulated
reflecting the self containment of this activation (Figure 3A). The
degree of upregulation varied between the genes in this pathway
with I-TAC and IP-10 being the most highly up-regulated
(average expression in the two cell types and patients) genes
(Figure 3B). A number of genes clustered around STAT1 were
associated with the IFN pathway, and examination of the common
list revealed another four genes (viperin, IFI44, IFIH1, G1P3)
related to the IFN pathway that were upregulated but not
mapped by the MetaCore program (Figure 3C). Finally, a number
of genes related to the ubiquitin-proteasome pathway also
appeared on the MetaCore map (HERC5, USP18 and Hdm2)
with several more (unmapped) genes appearing on the common
list (Figure 3D)
Upregulation of chemokines IP-10 and I-TAC upon
dengue infection
The two most highly upregulated common genes from the NF-
kB pathway were IP-10 (or CXCL10/IFN-inducible protein 10)
and I-TAC (or CXCL11/IFN-inducible I cell a chemoattractant)
(Figure 3B). In order to determine if this up-regulation of gene
transcription lead to translation and protein release, concentra-
tions of IP-10 and I-TAC protein in cell culture supernatant
following dengue infection were determined by ELISA. In both
the A549 and HepG2 infection models, dengue infected cells
produced moderate, but significant (compared to heat-inactivated
virus treated cells), concentrations of IP-10 (Figure 4A) and I-TAC
(Figure 4B) at 72 hrs, but not at earlier time points (data not
shown). We next investigated if these, or other, NF-kB induced
proteins were influencing dengue virus replication. Adding
dexamethasone to the HepG2 infection model to inhibit NF-kB
activation [25] prevented IP-10 and I-TAC production, but had
no effect on viral replication (data not shown). These results
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Figure 3. qPCR confirmed, common differentially expressed genes in HepG2, A549 cell lines and dengue patients. (A) A network of
direct interactions (highlighted by * in B, C & D) was identified by the MetaCore program. Arrow head indicates directional interaction. Green are
positive, red are negative, grey are neutral or unknown. Blue symbols indicate protein, green ones receptor ligand, red ones transcription factors,
yellow ones proteases and orange ones kinases or phosphatases. 32 confirmed genes cluster to three biological pathways; (B) NF-kB/chemokine-
genes (C) Type I IFN-mediated and (D) the ubiquitin-proteasome system. The fold increases of genes significantly differentially expressed in patients
and cell lines were combined to give a pooled mean (6 s.e.m.) in order to grade their relative importance.
doi:10.1371/journal.pntd.0000086.g003
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suggest that NF-kB activation, and IP-10 and I-TAC production,
do not have a direct effect on viral replication and are, rather,
simply part of the immune response to infection.
Serum concentrations of IP-10 and I-TAC in the ten dengue
fever patients described above, together with ten fever patients
who did not have dengue (viral PCR negative) were also
determined by ELISA. High concentrations of IP-10 (Figure 4C)
and I-TAC (Figure 4D) were present in the serum of dengue fever
patients. There was significantly more IP-10 in the serum of the
patients during the first (1–2 days after fever onset) and second (4–
5 days after fever onset) visits, compared to the convalescent serum
(P= 10215 and P= 10211, respectively) as well as to non-dengue
fever patient serum (P=1029 and P=1027, respectively). I-TAC
level was also significantly higher in first visit dengue patient serum
comparing to both the convalescent (P=1027) and non-dengue
fever (P=1026) patients. I-TAC levels in dengue fever patients at
the second visit were significantly lower than at first visit (Fig 4D).
A strong type I IFN response and the identification of
viperin as an IFN-induced anti-dengue molecule
We detected a large number of IFN response genes induced in
both cell line infections and in dengue patients (see Figure 3C). In
our study, viperin was one of the most highly upregulated genes in
the type I IFN response pathway. Viperin has previously been
identified as an IFN-induced anti-viral protein in HCMV and
HCV infection [26,27]. In order to investigate the role of viperin
in dengue infection, we used an established A549 cell line stably
overexpressing viperin (Vip) [26]. Comparing to infection in wild
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Figure 4. Culture supernatants of A549 and HepG2 cells infected with TSV01 (MOI 10) or heat-inactivated TSV-01 (HI-TSV01; MOI
10) for 72 hrs were analyzed for IP-10 (A) and I-TAC (B) by ELISA. Results are expressed as mean6s.e.m. where n = 3–5. Significance (P,0.05)
was determined by students t-test, comparing TSV01 to HI-TSV01 at each time point. Serum samples from dengue patients (n = 10) at first visit (1–
2 days after fever onset), second visit (4–5 days after fever onset), convalescence and from non-dengue fever patients (n = 10) at the first visit (1–
2 days after fever onset) were assayed for the presence of IP-10 (C) and I-TAC (D) by ELISA. Results are shown as a scatter plot with a bar indicating
the mean.
doi:10.1371/journal.pntd.0000086.g004
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type A549 cells (WT), viperin overexpressing cells were signif-
icantly resistant to viral replication, as shown by plaque assay two
days after infection (Figure 5A), with and without pre-treatment
with IFNb (+IFN; 500 U/ml). Although pre-treatment with IFNb
had the greater anti-viral effect, viperin over expression alone
resulted in a small, but significant, reduction in virus production
both with (P=0.038) and without (P=0.0004) IFNb pre-
treatment. These results suggest that viperin is an functional
component of the IFN-mediated response to dengue, and
demonstrate, for the first time, that viperin could be part of the
anti-dengue response.
Proteasome inhibitors inhibit dengue replication in the
HepG2 cell line
Ubiquitination, another pathway identified in our list of
common genes, is a key component of the immune system, the
conjugation of single, or multiple, ubiquitin molecules to a protein
targets it for defined subcellular localization, or destruction in the
proteasome [28]. Components of the ubiquitin-proteasome system
have been shown to be required for the maturation and release of
a number of viruses (see review [29]). In order to investigate the
role of ubiquitin-proteasome system in dengue infection, we
introduced proteasome inhibitors, MG-132 and ALLN, to the
HepG2 dengue infection model [30]. At lower concentrations,
both MG-132 and ALLN significantly reduced virus replication in
the cell lines by over 50% (Figure 5B). An examination of the
effects of these compounds on the integrity and viability of
inhibitor-treated cells using fluorescein diacetate revealed no
cytotoxicity at these concentrations (Figure 5C). Higher
concentrations of the inhibitors had an even greater effect
(.90% reduction in pfu/ml) but with a degree of cytotoxicity
(Figures 5B, 5C).
Discussion
Despite the fact that dengue is a major disease affecting the
tropical world, little is known of its pathogenesis due, partly, to the
lack of a suitable animal model and the complex cell interactions
in infected individuals. Using microarray analysis of gene
expression and high throughput quantitative real-time PCR, we
investigated the host response to dengue infection in cell lines and
in DF patients. We further validated our microarray results by
functional study of the identified genes. Although dendritic cells,
Langerhans cells and monocytes have been proposed as the
principle reservoirs of viral infection [4], it is not clear which other
tissues, if any, are targeted. Immunohistochemistry and in-situ
hybridisation studies of biopsies from DHF patients have indicated
that a range of tissues are infected by the virus, including cells in
the liver, spleen, lung, kidney and peripheral blood [5]. We chose
the HepG2 cell line as the primary cell model for this study as it
readily supported viral replication, and it is derived from the liver,
which might be of some clinical relevance. The A549 cell line was
included as it was also an excellent supporter of viral replication
even though there is, presumably, little or no clinical relevance.
The final clinical relevance came from the validation of the genes
in 10 DF patients from the Singapore EDEN cohort. The 10
patients were selected based on low platelet count, because of the
lack of WHO DHF/DSS manifestation in Singapore adult
patients. Despite the limited sample number, and the wide range
of collection times, variation between individuals at the same time
point was ruled out by statistical analysis. We believe that with
more patients, more genes that are differentially expressed would
be identified.
The overlap of upregulated genes, determined by quantitative
PCR, in the two cell systems and in patients removed any
responses that were unique to the cell type. In fact, we observed
cell type specific gene changes such as IL-8, PAI-1 and RANTES
that were upregulated in the cell lines but not the patient samples
while the anti-inflammatory cytokine IL-10 was upregulated in the
patient samples but not the cell lines, indicative of the effects of
multiple cell types in an in vivo system. Similarly, IFNb was
upregulated in the cell lines while IFNc was in patient samples.
However, it is the large overlap between the in vitro infection and
patient samples that warrants most attention.
The two most highly upregulated chemokines were IP-10 and I-
TAC. IP-10 and I-TAC are both ligands for the CXCR3
chemokine receptor and the production of these chemokines leads
to the recruitment of CXCR3 expressing T cells and NK cells
[31,32]. Increased IP-10 and I-TAC expression has been seen in
various viral infections, especially viral meningitis [33]. In SARS
patients, elevated IP-10 early in infection was shown to be
a predictor for a more severe outcome [34]. Neuronal IP-10 was
shown to be involved in the recruitment of T cells in West Nile
virus encephalitis [35]. Elevated I-TAC mRNA and protein has
also been found in the liver of chronic Hepatitis C patients [36]. In
dengue infection, various chemokines have previously been found
to be induced in dengue patients, including IL-8, MIP-1a, MIP-
1b, RANTES and MCP-1, but IP-10 and I-TAC have not been
examined (see review [37]).
In a dengue intracerebral mouse infection models, CXCR32/2
and IP102/2 mice both had higher mortality rate than wild type
mice after infection, indicating that IP-10 and CXCR3 receptors
are part of the host defense mechanism, most likely in recruitment
of T cells to the infection site [38]. IP-10 was also proposed to
compete with virus binding on the receptor in vitro [39]. However,
the relevance of this study to human patients is not clear. Although
IFNc, a/b and NF-kB could all induce the production of IP-10
and I-TAC, prevention of IP-10 and I-TAC via NF-kB inhibition
clearly reduced the IP-10 level in HepG2 cells. Furthermore, IFNb
and IFNc were not consistently upregulated in the two cell lines or
in DF patients in our study (data not shown). Therefore, we believe
that NF-kB activation rather than IFN induction played the major
role in elevated IP-10 and I-TAC in dengue infection. The inhibition
of NF-kB, and consequent IP-10 and I-TAC inhibition, had no
demonstrable effect on dengue replication in cell lines, suggesting the
more complex role for these chemokines in a multi-cellular in vivo
setting. Concentrations of each chemokine were significantly higher
during the early stages of dengue fever, while I-TAC levels were
reduced at the second visit, IP-10 levels remained high. The
persistently high level of IP-10 might also contribute to the
immunopathogenesis of dengue although this would require further
investigation. It may be that concentrations of IP-10 and I-TAC, in
combination with a viral antigen, could be used as an early marker
for dengue fever. It is interesting to note that the level of IP-10 and I-
TAC were independent of previous history of dengue infection, as
half of the ten tested patients were suffering from a secondary
infection. The common clinical feature of the ten selected patients
was the low platelet count at second visit. Because of the lack of
severe dengue cases (by WHO definition) in Singapore, the low
platelet count was used as the measure of severity by which the ten
patients from the cohort study were classified as having more severe
dengue fever. We cannot at this point make a link between the level
of IP-10, I-TAC and disease severity because of the small number of
cases used in this study, a more detailed clinical study, currently
underway, aims to determine if the concentrations of IP-10 and I-
TAC during early stages of infection are linked to the progression to
more severe forms of disease.
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The ability of IFN pre-treatment to inhibit subsequent dengue
replication has been previously reported [9,40], as has the
importance of IFN in the anti-viral response [41]. Our results
indicated that viperin was one of the most highly upregulated
genes in all models following dengue infection. Viperin encodes for
an IFN-inducible antiviral protein shown to be associated with the
endoplasmic reticulum and redistributed to the Golgi apparatus
and cytoplasmic vacuoles following human cytomegalovirus
(HCMV) infection [26]. The induction of viperin has been
suggested to be anti-viral in both HCMV [26] and hepatitis C
(HCV) [27] infections, but this is its first association with dengue
infection. The use of viperin overexpressing A549 cells demon-
strated that, in addition to being significantly upregulated during
infection, viperin is directly involved in the anti-viral response to
dengue, as shown by the suppression of dengue replication in the
presence of increased expression of viperin. This effect was not as
significant as the effect of IFNb alone suggesting that viperin is
only a part of the IFN-mediated response to dengue. The
molecular mechanism of the action of viperin to counter dengue
infection will need to be further studied.
The ubiquitin-proteasome system is the cellular machinery
involved in the conjugation of single or multiple ubiquitin
molecules to direct protein trafficking or degradation (reviewed
in [28]). In HCV infection, E6AP ubiquitin ligase was reported to
mediate the ubiquitination and degradation of the virus core
protein [42]. HCV polymerase has also been shown to interact
with a ubiquitin-like protein leading to its degradation [43]. In
dengue, ubiquitin-proteasome genes have not been reported to be
involved in the dengue virus life cycle although a recent
publication has shown that dengue envelope protein interacts
with SUMO-1 conjugating enzyme 9 (Ubc9) and that
overexpression of Ubc9 reduces virus production in a cell line [44].
Our TLDA results indicated that there was significant
upregulation of a number of ubiquitin-proteasome system related
genes during dengue virus replication but it was unclear if this
response was anti-viral or if the dengue virus utilised components
of the ubiquitin-proteasome system for replication. Use of
proteasome inhibitors, MG-132 and ALLN, significantly reduced
the release of dengue virus following infection of the HepG2 cell
line. Previously, it has been shown that the effect of proteasome
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Figure 5. The effect of viperin overexpression and proteasome inhibitors on viral growth. (A) Wildtype (WT) and viperin overexpressing
(Vip) A549 cells, with or without 12 hrs pre-treatment with IFNb (500 U/ml), were infected with dengue virus TSV01 (MOI 1) for 48 hrs. Plaque forming
units/ml in cell culture supernatant, as determined by plaque assay, are shown as mean (n = 3)6s.e.m. Significance (P,0.05) was determined by
students t-test, comparing wild type A549 (WT) to viperin overexpressing cell (Vip) a P value of 0.00004 was obtained. (B) HepG2 cells were incubated
with MG-132 (0.04 mM and 0.4 mM in DMSO) and ALLN (1 mM and 10 mM in DMSO) and DMSO alone for 2 hrs prior to infection with dengue virus
TSV01 (MOI 10) for 48 hrs. Plaque forming units/ml in cell culture supernatant, as determined by plaque assay, are shown as mean (n = 3)6s.e.m.
Significance (P,0.05) was determined by students t-test, comparing each treatment to DMSO alone. The cytotoxicity was measured in parallel using
FDA (C).
doi:10.1371/journal.pntd.0000086.g005
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inhibitors may be virus specific with these compounds less (or non-
) effective against virus such as influenza [45] and equine infectious
anemia virus [46]. The effect of proteasome inhibition on viral
replication appears to be mediated via a number of different
processes including the involvement of ubiquitin or the protea-
some in virus assembly [45], budding [47] and release and
maturation [48]. Further studies may elucidate the exact role the
ubiquitin-proteasome plays in dengue virus replication which may
involve trafficking of the virus to the plasma membrane or the
maturation and fusion of the virus upon release [49].
It is instructive to compare our results with those of a published
microarray study investigating host responses in patient blood
[50]. That study identified genes whose protein products are
expressed in the ER to be the most significantly enriched, which
directly overlaps with our identification of the ubiquitin pathway;
specifically including UBE2 and the PSMB genes. This may
represent a process fundamental to viral replication in any system.
In addition, Simmons et al. described host responses associated
with dengue shock syndrome that clearly overlap with our
interferon related gene list. In particular, G1P genes, OAS genes,
IFI genes and Mx genes were found in both studies, suggesting
that the amount of viral replication may be directly related to
clinical outcome.
Gene arrays of a number of cell systems during dengue infection
revealed many genes, and host response pathways, that were
upregulated during dengue infection. Further functional analyses
distinguished between host response pathways involved in
initiating an innate signaling response (NF-kB mediated genes
and IFN pathway) and those involved in virus replication
(ubiquitin-proteasome system). Specific components of the re-
sponse to virus, such as viperin and IP-10 and I-TAC have been
implicated in dengue infection for the first time. Further
investigation of these components, together with the precise role
of the ubiquitin-proteasome system in virus replication, may lead
to drug targets for dengue. The use of gene array in multiple cell
systems to investigate genes involved in virus replication, used in
concert with functional studies, has proved to be a valid approach
for discovery of novel markers and genes for understanding the
host response to dengue and, ultimately, therapeutics against
dengue.
Supporting Information
Table S1 HepG2 Microarray Gene List. List of HepG2
transcripts (n = 132), identified as differentially expressed by
SAM analysis, in response to dengue virus TSV01 compared to
heat inactivated virus 48 and 72 hours post infection. Transcripts
are placed in groups according to biological processes. qV is the
SAM calculated q value for each gene (following SAM significance
selection based on a Delta value calculated from the variance
between the sample sets, see Material and Methods). F.C. indicates
fold change. ‘‘-’’ represents no significant change. Genes selected
for real-time PCR validation through a TaqMan low density array
(TLDA) platform are indicated by a tick.
Found at: doi:10.1371/journal.pntd.0000086.s001 (0.28 MB
DOC)
Table S2 Quantitative PCR by Taqman based low density array
in HepG2, A549 and Singapore dengue fever patients. Fold
increase in gene expression as determined by quantitative PCR.
For HepG2 and A549, the fold change was calculated based on
dengue virus infection over heat-inactivated virus infection. For
dengue fever patients (Patients), the fold change was calculated
using patient blood samples collected at the first visit (,1–2 days
after onset of fever) over the convalescence (3–4 weeks after the
acute fever). Upregulation is shown in black and down-regulation
in red. ‘‘1.0’’ represents no significant change (significance
determined by q value ,5, see Material and Method). Genes
that were significantly up-regulated in at least one time point in
HepG2 and in at least one time point in A549 and in Patients are
indicated with P-values, calculated by standard student T test and
selected based on a cut off at P,0.05.
Found at: doi:10.1371/journal.pntd.0000086.s002 (0.19 MB
DOC)
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